<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03730389</url>
  </required_header>
  <id_info>
    <org_study_id>EPVL for 4-10mm ureteral stone</org_study_id>
    <nct_id>NCT03730389</nct_id>
  </id_info>
  <brief_title>External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone</brief_title>
  <official_title>External Physical Vibration Lithecbole(EPVL) Versus Traditional Treatment for 4-10 mm Ureteral Stone: A Multi-center Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guohua Zeng</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Guangzhou Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigator aims to perform a prospective and randomized controlled trial evaluating the&#xD;
      safety and efficacy of External Physical Vibration Lithecbole(EPVL) in treating 4-10 mm&#xD;
      ureteral stone.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with ureteral stones less than 10 mm, would receive observation for stone passage,&#xD;
      not requiring immediate surgery. There are many studies evaluating the effect of Medical&#xD;
      expulsive therapy in treating ureteral stones, including a-blockers, and calcium channel&#xD;
      blockers. Most of shuties concluded that the benefit of a-blockers might be among those with&#xD;
      larger (distal) stones. There is no good method for the removal of upper ureteral calculi,&#xD;
      except drinking water and exercising.&#xD;
&#xD;
      Recently, a new extracorporeal physical vibrational lithecbole (EPVL) device named Friend-I&#xD;
      EPVL (Zhengzhou Fu Jian Da Medical Instrument Co., Zhengzhou, China) has proven to be an&#xD;
      effective treatment for upper urinary tract residual calculi. The device was approved by the&#xD;
      Chinese food and drug administration in 2012. A Simple harmonic motion technology in&#xD;
      multi-direction was applied. The Lateral acceleration was provided by the physical vibration&#xD;
      device in the base through the harmonic vibration wave in the horizontal direction, which&#xD;
      induces the urinary stone separate with the kidney or ureter, and expands a moving space for&#xD;
      the stone. Meanwhile, an axial effect was produced to push the stone by the physical&#xD;
      vibration device in the handle through the harmonic vibration wave in the multi- direction.&#xD;
      So, we think that EPVL may be effective in treating ureteral stones.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>External Physical Vibration Lithecbole(EPVL) for ureteral stone</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Stone Expulsion</measure>
    <time_frame>14 days</time_frame>
    <description>The stone discharge rate of the two group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Stone Passage</measure>
    <time_frame>14 days</time_frame>
    <description>Time to stone elimination in days in patients with spontaneous elimination</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The rate of renal colic</measure>
    <time_frame>14 days</time_frame>
    <description>the mean rate of renal colic between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Required Analgesics</measure>
    <time_frame>14 days</time_frame>
    <description>the need for slow-released diclofenac tablet</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">208</enrollment>
  <condition>Ureteral Calculi</condition>
  <arm_group>
    <arm_group_label>EPVL Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In treatment group, patients were given one to three sessions of External Physical Vibration Lithecbole therapy in two weeks. These patients were also instructed to drink a minimum of 2500 ml water daily and take more exercise.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>patients with 4-10mm ureteral stone, were treated by traditional treatment methods, including drinking a minimum of 2500 ml water daily and taking more exercise.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>External Physical Vibration Lithecbole (EPVL)</intervention_name>
    <description>Using the the way of external physical vibration to promote separation of stones from ureteral mucosa and promoting the excretion of ureteral stones</description>
    <arm_group_label>EPVL Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Adults age 18 to 70 years&#xD;
&#xD;
          2. 4-10 mm single ureteral calculi&#xD;
&#xD;
          3. Normal serum creatinine&#xD;
&#xD;
          4. ASA grading: 1-2 levels.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or isolated kidney patients&#xD;
&#xD;
          2. Moderate or severe hydronephrosis&#xD;
&#xD;
          3. History of ureteral stricture&#xD;
&#xD;
          4. Multiple ureteral stones;&#xD;
&#xD;
          5. Acute urinary tract infection&#xD;
&#xD;
          6. Those who are taking Î±-receptor, calcium channel blocker or chinese medicine stone&#xD;
             shovel&#xD;
&#xD;
          7. Dysfunction of blood coagulation&#xD;
&#xD;
          8. Obese patients (body mass index &gt; 28 kg / m2);&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guohua Zeng, PH.D &amp; MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Guangzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guohua Zeng, Ph.D and M.D.</last_name>
    <phone>+86 13802916676</phone>
    <email>gzgyzgh@vip.tom.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510230</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guohua Zeng, Ph.D &amp; MD.</last_name>
      <phone>+86 13802916676</phone>
      <email>gzgyzgh@vip.sina.com</email>
    </contact>
    <investigator>
      <last_name>Guohua Zeng, Ph.D &amp; MD.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chao Cai, PH.D &amp; MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 2, 2018</study_first_submitted>
  <study_first_submitted_qc>November 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2018</study_first_posted>
  <last_update_submitted>November 2, 2018</last_update_submitted>
  <last_update_submitted_qc>November 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Guangzhou Medical University</investigator_affiliation>
    <investigator_full_name>Guohua Zeng</investigator_full_name>
    <investigator_title>Vice president</investigator_title>
  </responsible_party>
  <keyword>Ureteral Calculi</keyword>
  <keyword>External Physical Vibration Lithecbole (EPVL)</keyword>
  <keyword>Efficacy</keyword>
  <keyword>Safety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
    <mesh_term>Calculi</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

